In this recent interview, Johannes Schoen, Supply Network Quality Management Anti-Counterfeitng, Boehringer Ingelheim speaks to Andrea Charles from Pharma IQ, following facilitating the "Anti-Counterfeiting: Falsified Medicines Directive and beyond" roundtable at Cool Chain Logistics Europe 2013.
The global pharma market faces unprecedented complexities and pressures regarding the packaging and labelling of medicinal products. This guide examines the changes required for pharmaceutical packaging to meet the requirements of EU Falsified Medicines Directive (FMD) and the crucial questions to ask in order to achieve compliance.
This report provides a snapshot of the industry’s status in 2017 and gives valuable insights on: packaging and labelling regulatory compliance, artwork management, new technologies, patient compliance and tamper evidence packaging features. Commentary on the findings provided by global specialist secondary packaging provider Essentra. Download your free copy today.